13:00  Opening Remarks:  Ikuo Tooyama
Director of Research, Planning and International Affairs, SUMS
滋賀医科大学　理事(研究・企画・国際担当)　遠山育夫

Chair:
Makoto Urushitani, Director/Professor, MNRC, SUMS
滋賀医科大学　神経難病研究センター長、教授　漆谷　真

Shinsuke Ishigaki, Professor, MNRC, SUMS 同　教授　石垣　診祐

13:05-13:35

Dr. Lei Liu（ハーバード大学）
Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School
Title: A refresher of the amyloid hypothesis in a post Lecanemab approval era

13:35 -14:05

Dr. Yuichi Riku（愛知医科大学/名古屋大学）
Institute for Medical Sciences of Aging, Aichi Medical University; Department of Neurology, Nagoya University
Title: Mechanistic links between tauopathy and TDP-43 proteinopathy: from a view of human pathology

14:05-14:35

Dr. Shuo-Chien Ling（シンガポール国立大学）
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore
Title: Deciphering TDP-43 functions in health and disease

14:35-15:05

Dr. Yoshitaka Tamaki（滋賀医科大学）
Department of Neurology, Shiga University of Medical Science
Title: TDP-43 propagation in iPS-derived cerebral organoids

15:05

Closing Remarks: Masaki Nishimura, Professor, MNRC, SUMS
滋賀医科大学　神経難病研究センター　教授　西村　正樹